info@themedicimedicalresearch.com

+1 (954) 505-7480

Gastroenterology

- The Medici Medical Research brings clinical precision and operational excellence to gastrointestinal (GI) trials.

With experienced internal medicine leadership, our site has contributed to advancing therapies for both common and complex GI disorders through Phase II–IV clinical research.

Our trial expertise includes:

  • Irritable Bowel Syndrome (IBS) – evaluating new treatment classes and gut-brain interaction therapies
  • Gastrointestinal Infections & Inflammatory Disorders – focused on antimicrobial therapies, gut flora balance, and symptom reduction
  • Colorectal Cancer (CRC) Screening – studies utilizing non-invasive diagnostics and early detection biomarkers
  • Motility Disorders & Diabetic Gastropathy – trials addressing delayed gastric emptying and functional GI symptoms
  • NAFLD (Non-alcoholic Fatty Liver Disease) – biomarker-driven and imaging-supported intervention studies
  • Obesity-Linked GI Disorders – targeting absorption, metabolism, and GI-hormonal regulation

With experience managing medically complex patients and high-volume outpatient visits, our site is equipped to handle GI studies requiring integrated care, regular imaging, and lifestyle-related metrics. Our Principal Investigator brings years of internal medicine expertise into gastroenterology-focused trials, enhancing protocol fidelity and patient safety.